106 related articles for article (PubMed ID: 16957420)
1. MEK1/2 inhibition promotes Taxotere lethality in mammary tumors in vivo.
Yacoub A; Gilfor D; Hawkins W; Park MA; Hanna D; Hagan MP; Curiel DT; Fisher PB; Grant S; Dent P
Cancer Biol Ther; 2006 Oct; 5(10):1332-9. PubMed ID: 16957420
[TBL] [Abstract][Full Text] [Related]
2. Transient exposure of mammary tumors to PD184352 and UCN-01 causes tumor cell death in vivo and prolonged suppression of tumor regrowth.
Hawkins W; Mitchell C; McKinstry R; Gilfor D; Starkey J; Dai Y; Dawson K; Ramakrishnan V; Roberts JD; Yacoub A; Grant S; Dent P
Cancer Biol Ther; 2005 Nov; 4(11):1275-84. PubMed ID: 16319524
[TBL] [Abstract][Full Text] [Related]
3. Sequence dependent exposure of mammary carcinoma cells to Taxotere and the MEK1/2 inhibitor U0126 causes enhanced cell killing in vitro.
Yacoub A; Han SI; Caron R; Gilfor D; Mooberry S; Grant S; Dent P
Cancer Biol Ther; 2003; 2(6):670-6. PubMed ID: 14688474
[TBL] [Abstract][Full Text] [Related]
4. Transient exposure of carcinoma cells to RAS/MEK inhibitors and UCN-01 causes cell death in vitro and in vivo.
Hamed H; Hawkins W; Mitchell C; Gilfor D; Zhang G; Pei XY; Dai Y; Hagan MP; Roberts JD; Yacoub A; Grant S; Dent P
Mol Cancer Ther; 2008 Mar; 7(3):616-29. PubMed ID: 18347148
[TBL] [Abstract][Full Text] [Related]
5. Pharmocologic inhibitors of the mitogen activated protein kinase cascade have the potential to interact with ionizing radiation exposure to induce cell death in carcinoma cells by multiple mechanisms.
Qiao L; Yacoub A; McKinstry R; Park JS; Caron R; Fisher PB; Hagan MP; Grant S; Dent P
Cancer Biol Ther; 2002; 1(2):168-76. PubMed ID: 12170777
[TBL] [Abstract][Full Text] [Related]
6. Pharmacological and small interference RNA-mediated inhibition of breast cancer-associated fatty acid synthase (oncogenic antigen-519) synergistically enhances Taxol (paclitaxel)-induced cytotoxicity.
Menendez JA; Vellon L; Colomer R; Lupu R
Int J Cancer; 2005 May; 115(1):19-35. PubMed ID: 15657900
[TBL] [Abstract][Full Text] [Related]
7. Omega-6 polyunsaturated fatty acid gamma-linolenic acid (18:3n-6) enhances docetaxel (Taxotere) cytotoxicity in human breast carcinoma cells: Relationship to lipid peroxidation and HER-2/neu expression.
Menendez JA; Ropero S; Lupu R; Colomer R
Oncol Rep; 2004 Jun; 11(6):1241-52. PubMed ID: 15138562
[TBL] [Abstract][Full Text] [Related]
8. Comparative in vitro cytotoxicity of taxol and Taxotere against cisplatin-sensitive and -resistant human ovarian carcinoma cell lines.
Kelland LR; Abel G
Cancer Chemother Pharmacol; 1992; 30(6):444-50. PubMed ID: 1356649
[TBL] [Abstract][Full Text] [Related]
9. 'Rings' of F-actin form around the nucleus in cultured human MCF7 adenocarcinoma cells upon exposure to both taxol and taxotere.
Rosenblum MD; Shivers RR
Comp Biochem Physiol C Toxicol Pharmacol; 2000 Jan; 125(1):121-31. PubMed ID: 11790336
[TBL] [Abstract][Full Text] [Related]
10. Pharmacologic mitogen-activated protein/extracellular signal-regulated kinase kinase/mitogen-activated protein kinase inhibitors interact synergistically with STI571 to induce apoptosis in Bcr/Abl-expressing human leukemia cells.
Yu C; Krystal G; Varticovksi L; McKinstry R; Rahmani M; Dent P; Grant S
Cancer Res; 2002 Jan; 62(1):188-99. PubMed ID: 11782377
[TBL] [Abstract][Full Text] [Related]
11. Enhancing CHK1 inhibitor lethality in glioblastoma.
Tang Y; Dai Y; Grant S; Dent P
Cancer Biol Ther; 2012 Apr; 13(6):379-88. PubMed ID: 22313687
[TBL] [Abstract][Full Text] [Related]
12. Inactivation of NF-kappaB by 3,3'-diindolylmethane contributes to increased apoptosis induced by chemotherapeutic agent in breast cancer cells.
Rahman KM; Ali S; Aboukameel A; Sarkar SH; Wang Z; Philip PA; Sakr WA; Raz A
Mol Cancer Ther; 2007 Oct; 6(10):2757-65. PubMed ID: 17913854
[TBL] [Abstract][Full Text] [Related]
13. Tumor inhibitory effect of gefitinib (ZD1839, Iressa) and taxane combination therapy in EGFR-overexpressing breast cancer cell lines (MCF7/ADR, MDA-MB-231).
Takabatake D; Fujita T; Shien T; Kawasaki K; Taira N; Yoshitomi S; Takahashi H; Ishibe Y; Ogasawara Y; Doihara H
Int J Cancer; 2007 Jan; 120(1):181-8. PubMed ID: 17036319
[TBL] [Abstract][Full Text] [Related]
14. Inhibitors of MEK1/2 interact with UCN-01 to induce apoptosis and reduce colony formation in mammary and prostate carcinoma cells.
McKinstry R; Qiao L; Yacoub A; Dai Y; Decker R; Holt S; Hagan MP; Grant S; Dent P
Cancer Biol Ther; 2002; 1(3):243-53. PubMed ID: 12432271
[TBL] [Abstract][Full Text] [Related]
15. Exogenous supplementation with omega-3 polyunsaturated fatty acid docosahexaenoic acid (DHA; 22:6n-3) synergistically enhances taxane cytotoxicity and downregulates Her-2/neu (c-erbB-2) oncogene expression in human breast cancer cells.
Menendez JA; Lupu R; Colomer R
Eur J Cancer Prev; 2005 Jun; 14(3):263-70. PubMed ID: 15901996
[TBL] [Abstract][Full Text] [Related]
16. Targeted nanoassembly loaded with docetaxel improves intracellular drug delivery and efficacy in murine breast cancer model.
Gao Y; Chen L; Gu W; Xi Y; Lin L; Li Y
Mol Pharm; 2008; 5(6):1044-54. PubMed ID: 19434922
[TBL] [Abstract][Full Text] [Related]
17. Antitumor effects of novel highly hydrophilic and non-ATP-competitive MEK1/2 inhibitor, SMK-17.
Kiga M; Tanzawa F; Iwasaki S; Inaba F; Fujiwara K; Iwadare H; Echigo T; Nakamura Y; Shibata T; Suzuki K; Yasumatsu I; Nakayama A; Sasazawa Y; Tashiro E; Imoto M; Kurakata S
Anticancer Drugs; 2012 Jan; 23(1):119-30. PubMed ID: 22008853
[TBL] [Abstract][Full Text] [Related]
18. In vitro comparative evaluation of trastuzumab (Herceptin) combined with paclitaxel (Taxol) or docetaxel (Taxotere) in HER2-expressing human breast cancer cell lines.
Merlin JL; Barberi-Heyob M; Bachmann N
Ann Oncol; 2002 Nov; 13(11):1743-8. PubMed ID: 12419746
[TBL] [Abstract][Full Text] [Related]
19. The farnesyl protein transferase inhibitor SCH66336 synergizes with taxanes in vitro and enhances their antitumor activity in vivo.
Shi B; Yaremko B; Hajian G; Terracina G; Bishop WR; Liu M; Nielsen LL
Cancer Chemother Pharmacol; 2000; 46(5):387-93. PubMed ID: 11127943
[TBL] [Abstract][Full Text] [Related]
20. Cetuximab conjugated vitamin E TPGS micelles for targeted delivery of docetaxel for treatment of triple negative breast cancers.
Kutty RV; Feng SS
Biomaterials; 2013 Dec; 34(38):10160-71. PubMed ID: 24090836
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
